Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
Completed · Phase 1/Phase 2
Conditions studied: Esophageal Cancer
In brief
RATIONALE: Photodynamic therapy uses light and drugs that make tumor cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by tumor cells and, when exposed to light, become active and kill the tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of photodynamic therapy with HPPH in treating patients who have obstructive esophageal tumors.
Key facts
- Study ID
- NCT00060268
- Run by
- Roswell Park Cancer Institute
- People needed
- 11
- Starts
- 1997-01-01
- Expected to finish
- 2004-06-01
- Last updated by the study team
- 2011-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.